Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇮🇪IE · Medicine#3210K to 30K
- 🇮🇸IS · Medicine#1003K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
9.1K to 28K🎙 Weekly cadence·27 episodes·Last published 4mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
13K to 40K🇮🇪75%🇮🇸25% - Active Followers
Loyal subscribers who consistently listen
3.9K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Lipid Legends: Drs. James Underberg and Daniel Soffer Address Key Clinical Challenges in Hypertriglyceridemia (HTG)
Dec 31, 2025
Unknown duration
Lipid Legends: Drs. James Underberg and Anne Carol Goldberg Examine the Presentation and Management of Homozygous Familial Hypercholesterolemia
Dec 31, 2025
Unknown duration
Lipid Legends: Drs. James Underberg and Zahid Ahmad Distinguish Lipodystrophy Syndromes and Their Treatment Approaches
Dec 22, 2025
Unknown duration
Lipid Legends: Drs. James Underberg and Don Wilson Review Diagnosis and Individualized Treatment of Pediatric Lipid Disorders
Dec 22, 2025
Unknown duration
Lipid Legends: Drs. James Underberg and Pam Taub Discuss Reducing Cardiovascular Risk Through LDL-C Management
Dec 15, 2025
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 |  Lipid Legends: Drs. James Underberg and Daniel Soffer Address Key Clinical Challenges in Hypertriglyceridemia (HTG) | In this episode, experts in the field summarize key clinical considerations in the assessment and treatment of patients with hypertriglyceridemia. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251231/5lipid-legends | — | ||||||
| 12/31/25 |  Lipid Legends: Drs. James Underberg and Anne Carol Goldberg Examine the Presentation and Management of Homozygous Familial Hypercholesterolemia | In this episode, experts in the field identify the presentation and appropriate management strategies for patients with homozygous familial hypercholesterolemia (HoFH). To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251231/6lipid-legends | — | ||||||
| 12/22/25 |  Lipid Legends: Drs. James Underberg and Zahid Ahmad Distinguish Lipodystrophy Syndromes and Their Treatment Approaches | In this episode, experts in the field distinguish between different types of lipodystrophy syndromes and their treatment approaches. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251222/3lipid-legends | — | ||||||
| 12/22/25 |  Lipid Legends: Drs. James Underberg and Don Wilson Review Diagnosis and Individualized Treatment of Pediatric Lipid Disorders | In this episode, experts in the field assess the evaluation and treatment of pediatric patients with lipid disorders, including familial hypercholesterolemia (FH) and lipodystrophy. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251222/4lipid-legends | — | ||||||
| 12/15/25 |  Lipid Legends: Drs. James Underberg and Pam Taub Discuss Reducing Cardiovascular Risk Through LDL-C Management | In this podcast, experts in the field review current recommendations for cardiovascular risk assessment and the importance of early and sustained LDL-C lowering in high-risk patients. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251215/1lipid-legends | — | ||||||
| 12/15/25 |  Lipid Legends: Drs. James Underberg and Howard Weintraub Describe the Role of Lp(a) and Potential Impact of Emerging Therapies | The Lipid Legends podcast series highlights accomplished lipid specialists to highlight clinical challenges and provide actionable insights into disorders. In this episode, experts in the field describe the role of Lp(a) in atherogenesis and the potential impact of emerging therapies on clinical outcomes. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://www.healio.com/cme/mededtalks/cardiology/20251215/2lipid-legends | — | ||||||
| 3/14/25 |  Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Alan Brown: Lp(a) – What You Need to Know | In this podcast, expert clinicians will discuss the role of lipoprotein(a) [Lp(a)] in atherogenesis and emerging therapies that reduce Lp(a). To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/cardiology/20250303/5-lipid-legends-with-your-host-dr-ronald-codario | — | ||||||
| 2/28/25 |  Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. James Underberg: Familial Hypercholesterolemia – Risk Assessment and Treatment | In this podcast, expert clinicians will assess the latest understanding regarding homozygous and heterozygous familial hypercholesterolemia (FH), risk assessment, and options for management. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/cardiology/20250211/3-lipid-legends-with-your-host-dr-ronald-codario-featuring-dr-james-underberg Read More | — | ||||||
| 1/15/25 |  Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Peter Toth: PCSK9 Inhibition | In this podcast, expert clinicians will review the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in reducing low-density lipoprotein cholesterol (LDL-C) and reducing cardiovascular risk. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/cardiology/20250102/4-lipid-legends-with-your-host-dr-ronald-codario-featuring-dr-peter-toth-pcsk9-inhibition | — | ||||||
| 12/16/24 |  Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Thomas Dayspring: Perils of Hypertriglyceridemia | In this podcast, expert clinicians will discuss clinical challenges related to hypertriglyceridemia and its therapies. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/cardiology/20241125/6-lipid-legends-with-your-host-dr-ronald-codario-featuring-dr-thomas-dayspring-perils | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/15/24 |  Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Christie Ballantyne: CETP Inhibition | In this podcast, expert clinicians will discuss the latest evidence regarding the role of cholesteryl ester transfer protein (CETP) inhibitors in the management of patients with dyslipidemia. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/cardiology/20241104/2-lipid-legends-with-your-host-dr-ronald-codario | — | ||||||
| 10/31/24 |  Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Michael Davidson: Assessing Cardiovascular Risk | In this podcast, expert clinicians will discuss the latest recommendations to assess cardiovascular risk, residual risk, and low-density lipoprotein cholesterol (LDL-C) goals for therapy. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/cardiology/20241028/1-lipid-legends-with-your-host-dr-ronald-codario | — | ||||||
| 8/23/23 |  sGC Modulators in HFrEF: MOA, Clinical Evidence, With Drs. IIeana Pina and Javed Butler | In this podcast, expert clinicians will discuss the mechanism of action of and clinical evidence for the use of soluble guanylate cyclase (sGC) modulators in heart failure with reduced ejection fraction (HFrEF). | — | ||||||
| 8/23/23 |  Updated Guidelines Recommendations for the Management of HFrEF and Worsening HF, With Drs. Ileana Pina and Shelley Zieroth | In this podcast, expert clinicians will discuss the updated guideline recommendations for the management of heart failure with reduced ejection fraction (HFrEF) and worsening HF. | — | ||||||
| 8/23/23 |  Burden of HFrEF and Worsening HF, With Drs. Ileana Piña and Javed Butler | In this podcast, expert clinicians will discuss the burden of HFrEF and worsening HF. | — | ||||||
| 6/2/22 | Case Discussion: ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera | In this podcast, expert clinicians will discuss evidence-based management of CV risk reduction. | — | ||||||
| 6/2/22 | Clinical Evidence for Omega-3 Polyunsaturated Fatty Acids for Managing ASCVD Risk With Drs. Peter Toth and Pam Taub | Clinical Evidence for Omega-3 PUFAs for Managing CV Risk with Drs. Peter Toth and Pam Taub. | — | ||||||
| 6/2/22 | The Impact of Omega-3 PUFAs on ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera | The Impact of Omega-3 PUFAs on CV Risk Reduction with Drs. Peter Toth and Amit Khera. | — | ||||||
| 6/2/22 | The Role of Inflammation in Atherosclerosis With Drs. Peter Toth and Pam Taub | In this podcast, expert clinicians will discuss the role of inflammation in atherosclerosis. | — | ||||||
| 4/27/22 | Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll | In this podcast, expert clinicians will discuss management selection for embolic stroke with a PFO. | — | ||||||
| 4/27/22 | Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll | In this podcast, expert clinicians will discuss treatment options for embolic stroke due to a PFO. | — | ||||||
| 4/27/22 | Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner | In this podcast, expert clinicians will discuss the current guidelines for the management of embolic stroke with a PFO. | — | ||||||
| 4/27/22 | Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner | In this podcast, expert clinicians will discuss challenges in the diagnosis of embolic stroke with a PFO. | — | ||||||
| 4/29/21 | PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner | In this podcast, expert clinicians will share procedural pearls for PFO closure and important considerations to optimize patient outcomes. | — | ||||||
| 4/29/21 | Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner | In this podcast, expert clinicians will discuss management of patients with cryptogenic stroke as well as strategies for applying new guideline recommendations into practice. | — | ||||||
Showing 25 of 39
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.